InflaRx Statistics
Total Valuation
InflaRx has a market cap or net worth of $83.33 million. The enterprise value is $27.67 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InflaRx has 67.75 million shares outstanding. The number of shares has increased by 5.64% in one year.
| Current Share Class | 67.75M |
| Shares Outstanding | 67.75M |
| Shares Change (YoY) | +5.64% |
| Shares Change (QoQ) | +7.00% |
| Owned by Insiders (%) | 6.38% |
| Owned by Institutions (%) | 15.24% |
| Float | 56.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 435.77 |
| Forward PS | 103.98 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 144.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.10 |
| Quick Ratio | 3.08 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,043.00 |
Financial Efficiency
Return on equity (ROE) is -65.07% and return on invested capital (ROIC) is -46.61%.
| Return on Equity (ROE) | -65.07% |
| Return on Assets (ROA) | -39.42% |
| Return on Invested Capital (ROIC) | -46.61% |
| Return on Capital Employed (ROCE) | -91.64% |
| Revenue Per Employee | $2,584 |
| Profits Per Employee | -$718,791 |
| Employee Count | 74 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.70 |
Taxes
In the past 12 months, InflaRx has paid $6,127 in taxes.
| Income Tax | 6,127 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.99% in the last 52 weeks. The beta is 1.45, so InflaRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -13.99% |
| 50-Day Moving Average | 1.02 |
| 200-Day Moving Average | 1.50 |
| Relative Strength Index (RSI) | 49.40 |
| Average Volume (20 Days) | 994,186 |
Short Selling Information
| Short Interest | 453,205 |
| Short Previous Month | 908,548 |
| Short % of Shares Out | 0.71% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.87 |
Income Statement
In the last 12 months, InflaRx had revenue of $191,224 and -$53.19 million in losses. Loss per share was -$0.85.
| Revenue | 191,224 |
| Gross Profit | -5.87M |
| Operating Income | -61.65M |
| Pretax Income | -51.25M |
| Net Income | -53.19M |
| EBITDA | -61.63M |
| EBIT | -61.65M |
| Loss Per Share | -$0.85 |
Full Income StatementBalance Sheet
The company has $56.37 million in cash and $703,596 in debt, giving a net cash position of $55.66 million or $0.82 per share.
| Cash & Cash Equivalents | 56.37M |
| Total Debt | 703,596 |
| Net Cash | 55.66M |
| Net Cash Per Share | $0.82 |
| Equity (Book Value) | 66.99M |
| Book Value Per Share | 0.99 |
| Working Capital | 58.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.64 million and capital expenditures -$51,948, giving a free cash flow of -$50.78 million.
| Operating Cash Flow | -50.64M |
| Capital Expenditures | -51,948 |
| Free Cash Flow | -50.78M |
| FCF Per Share | -$0.75 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -32,241.93% |
| Pretax Margin | -27,812.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InflaRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.64% |
| Shareholder Yield | -5.64% |
| Earnings Yield | -63.83% |
| FCF Yield | -60.94% |
Analyst Forecast
The average price target for InflaRx is $7.40, which is 501.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.40 |
| Price Target Difference | 501.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 113.91% |
| EPS Growth Forecast (5Y) | -13.62% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InflaRx has an Altman Z-Score of -4.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.92 |
| Piotroski F-Score | 2 |
